首页 | 本学科首页   官方微博 | 高级检索  
     


A novel PSEN1 H163P mutation in a patient with early-onset Alzheimer's disease: Clinical,neuroimaging, and neuropathological findings
Authors:Jungeun Kim  Eva Bagyinszky  Young Hee Chang  Gheeyoung Choe  Byung-Ok Choi  Seong Soo A. An  SangYun Kim
Affiliation:1. Department of Neurology, Seoul National University College of Medicine in Seoul National Bundang Hospital, Seoul, South Korea;2. Department of Pathology, Seoul National University College of Medicine in Seoul National Bundang Hospital, Seoul, South Korea;3. College of Bionano Technology, Gachon University, 1342 Sungnam-daero, Sujung-gu, Sungnam-si, Gyeonggi-do, South Korea;4. Department of Neurology, Ewha Womans University, School of Medicine, Seoul, South Korea
Abstract:We report a novel presenilin 1 gene (PSEN1) mutation (H163P) in a patient with sporadic early-onset Alzheimer's disease. Clinical, molecular, and neuropathological examinations were performed on an index patient, who presented at the age of 34 years with depression and memory disturbances. At the age of 36 years, she exhibited seizures and myoclonus, cerebellar ataxia, and Parkinsonism. A novel mutation at codon 163 was found in PSEN1, which was changed from histidine to proline. Severe atrophy was noted in the frontal and temporal lobes of the brain. A histopathological examination of the frontal cortex revealed senile plaques and severe neurofibrillary tangles. PSEN1 codon 163 could be a mutational hot spot in early-onset Alzheimer's disease, and may result in a homogeneous phenotype similar to that of other patients with codon-163 mutations; thus, widening the spectrum of PSEN1 codon-163-linked phenotypes.
Keywords:Early onset   Alzheimer's disease   PSEN1 mutation
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号